| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3293104 | Gastroenterology | 2012 | 16 Pages |
Abstract
Differences in expression of ISGs might account for the greater response of patients with AHC, compared with those with CHC, to treatment with pegIFN-α and ribavirin. Specifically, USP18 is up-regulated in liver samples of patients with CHC that did not respond to therapy, but not in patients with AHC.
Keywords
MAVSpegylated interferon alfaISGPHHCHCPegIFN-αhpfAHCpStat1mRNASVRPhosphorylated STAT1Janus kinaseprimary human hepatocytesmessenger RNAreverse-transcriptionhigh-power fieldchronic hepatitis CAcute hepatitis CHepatitis C virusHCVpolymerase chain reactionPCRSustained virologic responseImmune responsemitochondrial antiviral signaling proteinJAKinterferon-stimulated gene
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Michael T. Dill, Zuzanna Makowska, Francois H.T. Duong, Franzisca Merkofer, Magdalena Filipowicz, Thomas F. Baumert, Luigi Tornillo, Luigi Terracciano, Markus H. Heim,